Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of High Bleeding Risk Patients After Bioresorbable Polymer-Coated Stent With Abbreviated vs Prolonged DAPT
KCT0002974Phase 4Completed
- Sponsor
- European Cardiovascular Research Institute
- Start
- Jun 2017
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin + P2Y12 antagonist in coronary arteriosclerosis, sponsored by European Cardiovascular Research Institute. Started Jun 2017; status: completed.
02
Drugs
aspirin + P2Y12 antagonist
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0002974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002974.